Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- Betsi Cadwaladr University Health Board · Body governed by public law
- Supplier
- Randox Laboratories Ltd SME
- Value
- £47,000
- Procedure
- Open procedure
- Sector
- Health & social care · Blood analysis services (CPV 85111810)
- Region
- Wales
- Official notice
- 067988-2026 on Find a Tender
- Timeline
-
- Contract date17 Jul 2026
- Published17 Jul 2026Published the same day
Description
This is a Provider Selection Regime (PSR) Intention to Award Notice. Betsi Cadwaladr University Health Board (BCUHB) intends to to award a contract under the Most Suitable Provider Process under The Health Services (Provider Selection Regime) (Wales) Regulations 2025 for the provision of outsourced pathology testing services for HFE genes, including sample extraction. In accordance with the Most Suitable Provider Process, the Contracting Authority has considered which providers are capable of delivering the service and, having regard to the key criteria and all relevant information available at this time, considers that it has identified the most suitable provider to deliver the requirement. The Contracting Authority intends to award a single contract to the most suitable provider. This Intention to Award Notice will be published for a period of at least 8 days. Additional information: This is a Provider Selection Regime (PSR) Intention to Award a Contract Notice. The contract is subj…
About the supplier
Randox Laboratories Ltd: every public contract they have won, plus their Companies House record (company NI015738).